EUVIMEDAtrasti EUVIMED
Crossref

Determination of Xanthine Oxidase and Calprotectin and Some Biochemical Parameters in Diabetic Nephropathy Serum of Iraqi Patients

Zina J. Ghaib, Rasha M. Kamil, Amal Jabbar Ghaib

Journal of Pioneering Medical Sciences · 2026-07-05 · 15 (6) · 168-173

DOI: 10.47310/jpms2026150622 ↗

At a glance

Journal article in Journal of Pioneering Medical Sciences, published online on 2026-07-05. Written by Zina J. Ghaib and 2 co-authors.

SantraukaBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Objective

Diabetic Nephropathy (DN) is a major long-term severe microvascular complication of diabetes mellitus and the current leading cause of end-stage kidney disease. It accounts for up to 40% of patients requiring renal replacement therapy. The risk of end‑stage kidney failure has been associated with an increase in the level of a new biomarker, xanthine oxidase, and calprotectin, used to assess the severity of kidney injury.

Methods

Blood samples were collected from 30 individuals diagnosed with DN disease and 30 individuals with diabetes but without kidney disease, who visited the National Diabetes Centre at the University of Al-Mustansiriyah, along with 28 control subjects. An enzyme‑linked immunosorbent assay was used to assess serum xanthine oxidase (XOD) and Calprotectin (Calp), and a UV-Visible spectrophotometer was used to evaluate other biochemical parameters.

Results

The mean serum XOD activity (2.04±0.38 ng/ml) in DN was significantly greater than the corresponding values for the controls (0.95±0.12 ng/ml), and the mean serum Calp (173.46±29.56 ng/ml) in DN Patients was significantly greater than the corresponding values for the controls (43.26±5.88 ng/ml). The optimal cut-off value for CALP sensitivity of 86.3% and specificity of 82.1%, and the AUC for control and DN is 0.844, and for control versus diabetic, it is 0.853, while XOD activity showed a high sensitivity of 76.5% and specificity of 89.9% to distinguish between control and DN, so the results show the AUC = 0.833 for control vs. DN, and AUC for control and diabetes is 0.863. These high sensitivity and specificity values highlight the reliability of CALP and XOD as significantly associated with diabetic nephropathy.

Cite

APA

Ghaib, Z. J., Kamil, R. M., & Ghaib, A. J. (2026). Determination of Xanthine Oxidase and Calprotectin and Some Biochemical Parameters in Diabetic Nephropathy Serum of Iraqi Patients. Journal of Pioneering Medical Sciences, 15(6), 168-173. https://doi.org/10.47310/jpms2026150622

Vancouver

Ghaib ZJ, Kamil RM, Ghaib AJ. Determination of Xanthine Oxidase and Calprotectin and Some Biochemical Parameters in Diabetic Nephropathy Serum of Iraqi Patients. Journal of Pioneering Medical Sciences. 2026;15(6):168-173. doi:10.47310/jpms2026150622

BibTeX
@article{Ghaib2026,
  author = {Ghaib, Zina J. and Kamil, Rasha M. and Ghaib, Amal Jabbar},
  title = {Determination of Xanthine Oxidase and Calprotectin and Some Biochemical Parameters in Diabetic Nephropathy Serum of Iraqi Patients},
  journal = {Journal of Pioneering Medical Sciences},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {168--173},
  doi = {10.47310/jpms2026150622}
}
Start for free →